Published in Arch Gen Psychiatry on December 01, 2007
Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci (2009) 4.16
Meta-analysis of functional neuroimaging studies of emotion perception and experience in schizophrenia. Biol Psychiatry (2011) 2.76
From maps to mechanisms through neuroimaging of schizophrenia. Nature (2010) 2.28
Fear, faces, and the human amygdala. Curr Opin Neurobiol (2008) 2.23
Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophr Res (2011) 1.73
Neuroimaging of the Philadelphia neurodevelopmental cohort. Neuroimage (2013) 1.61
Extinction memory is impaired in schizophrenia. Biol Psychiatry (2008) 1.50
CNTRICS final task selection: social cognitive and affective neuroscience-based measures. Schizophr Bull (2008) 1.46
Facial emotion processing in schizophrenia: a meta-analysis of functional neuroimaging data. Schizophr Bull (2009) 1.40
The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question. Neurosci Biobehav Rev (2009) 1.30
Autism spectrum disorders and schizophrenia: meta-analysis of the neural correlates of social cognition. PLoS One (2011) 1.26
"It's Not What You Say, But How You Say it": A Reciprocal Temporo-frontal Network for Affective Prosody. Front Hum Neurosci (2010) 1.23
Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia. Psychopharmacology (Berl) (2011) 1.19
Emotion effects on attention, amygdala activation, and functional connectivity in schizophrenia. Schizophr Bull (2011) 1.17
Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res (2013) 1.16
Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studies. Schizophr Bull (2010) 1.16
Impaired modulation of attention and emotion in schizophrenia. Schizophr Bull (2008) 1.15
Association of enhanced limbic response to threat with decreased cortical facial recognition memory response in schizophrenia. Am J Psychiatry (2010) 1.11
Abnormal structure or function of the amygdala is a common component of neurodevelopmental disorders. Neuropsychologia (2010) 1.06
An investigation of the relationship between activation of a social cognitive neural network and social functioning. Schizophr Bull (2008) 1.05
Functional magnetic resonance imaging in schizophrenia. Dialogues Clin Neurosci (2010) 1.00
Dysfunction of a cortical midline network during emotional appraisals in schizophrenia. Schizophr Bull (2009) 1.00
Neurobiological background of negative symptoms. Eur Arch Psychiatry Clin Neurosci (2015) 1.00
Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia. Schizophr Bull (2010) 0.97
Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities. Mol Psychiatry (2014) 0.97
Lack of cortico-limbic coupling in bipolar disorder and schizophrenia during emotion regulation. Transl Psychiatry (2012) 0.95
How do schizophrenia patients use visual information to decode facial emotion? Schizophr Bull (2010) 0.94
Abnormal superior temporal connectivity during fear perception in schizophrenia. Schizophr Bull (2008) 0.93
Neural changes following cognitive behaviour therapy for psychosis: a longitudinal study. Brain (2011) 0.92
18FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2009) 0.92
Changes in prefrontal and amygdala activity during olanzapine treatment in schizophrenia. Psychiatry Res (2009) 0.91
Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol (2011) 0.90
Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge. Psychopharmacology (Berl) (2011) 0.89
Frontolimbic responses to emotional face memory: the neural correlates of first impressions. Hum Brain Mapp (2009) 0.89
Maladaptive defensive behaviours in monoamine oxidase A-deficient mice. Int J Neuropsychopharmacol (2010) 0.89
Differential patterns of initial and sustained responses in amygdala and cortical regions to emotional stimuli in schizophrenia patients and healthy participants. J Psychiatry Neurosci (2010) 0.88
Functional MRI of verbal self-monitoring in schizophrenia: performance and illness-specific effects. Schizophr Bull (2008) 0.88
Influence of emotional processing on working memory in schizophrenia. Schizophr Bull (2010) 0.88
Functional neuroimaging abnormalities in youth with psychosis spectrum symptoms. JAMA Psychiatry (2015) 0.86
Limbic activity in antipsychotic naïve first-episode psychotic subjects during facial emotion discrimination. Eur Arch Psychiatry Clin Neurosci (2013) 0.85
Ventrolateral prefrontal cortex and the effects of task demand context on facial affect appraisal in schizophrenia. Soc Cogn Affect Neurosci (2010) 0.84
Recent advances in understanding schizophrenia. F1000Prime Rep (2014) 0.83
Selective emotional processing deficits to social vignettes in schizophrenia: an ERP study. Schizophr Bull (2009) 0.83
Early sensory-perceptual processing deficits for affectively valenced inputs are more pronounced in schizophrenia patients with a history of violence than in their non-violent peers. Soc Cogn Affect Neurosci (2012) 0.82
Brain mapping biomarkers of socio-emotional processing in schizophrenia. Schizophr Bull (2011) 0.82
Emotion processing in women with schizophrenia is menstrual cycle phase and affective valence dependent: an FMRI study. ISRN Psychiatry (2012) 0.81
Gonadectomy negatively impacts social behavior of adolescent male primates. Horm Behav (2009) 0.80
Opposing amygdala and ventral striatum connectivity during emotion identification. Brain Cogn (2011) 0.80
Unseen Affective Faces Influence Person Perception Judgments in Schizophrenia. Clin Psychol Sci (2014) 0.80
Hippocampal temporal-parietal junction interaction in the production of psychotic symptoms: a framework for understanding the schizophrenic syndrome. Front Hum Neurosci (2012) 0.79
Association between polygenic risk for schizophrenia, neurocognition and social cognition across development. Transl Psychiatry (2016) 0.78
Social alienation in schizophrenia patients: association with insula responsiveness to facial expressions of disgust. PLoS One (2014) 0.78
Negative symptoms in youths with psychosis spectrum features: complementary scales in relation to neurocognitive performance and function. Schizophr Res (2015) 0.78
Altered threat and safety neural processing linked to persecutory delusions in schizophrenia: a two-task fMRI study. Psychiatry Res (2015) 0.77
Impairment in emotional modulation of attention and memory in schizophrenia. Schizophr Res (2014) 0.77
Deficits in Early Stages of Face Processing in Schizophrenia: A Systematic Review of the P100 Component. Schizophr Bull (2015) 0.77
Structural brain alterations associated with schizophrenia preceded by conduct disorder: a common and distinct subtype of schizophrenia? Schizophr Bull (2012) 0.77
Memory in health and in schizophrenia. Dialogues Clin Neurosci (2013) 0.77
Affective Flattening in Patients with Schizophrenia: Differential Association with Amygdala Response to Threat-Related Facial Expression under Automatic and Controlled Processing Conditions. Psychiatry Investig (2015) 0.76
Social cognition as an RDoC domain. Am J Med Genet B Neuropsychiatr Genet (2015) 0.76
Mapping Depression in Schizophrenia: A Functional Magnetic Resonance Imaging Study. Schizophr Bull (2015) 0.76
The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions. Schizophr Res (2010) 0.76
Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study. Psychol Med (2016) 0.75
Biases in facial and vocal emotion recognition in chronic schizophrenia. Front Psychol (2014) 0.75
Impaired visual cortical processing of affective facial information in schizophrenia. Clin Psychol Sci (2015) 0.75
Linking persistent negative symptoms to amygdala-hippocampus structure in first-episode psychosis. Transl Psychiatry (2017) 0.75
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care (2011) 5.63
The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis (2010) 5.34
Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med (2003) 5.09
Impact of in-scanner head motion on multiple measures of functional connectivity: relevance for studies of neurodevelopment in youth. Neuroimage (2012) 4.84
An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data. Neuroimage (2012) 4.30
COMPARE: classification of morphological patterns using adaptive regional elements. IEEE Trans Med Imaging (2007) 3.72
The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2005) 3.24
Sex differences in the structural connectome of the human brain. Proc Natl Acad Sci U S A (2013) 3.06
Point of use household drinking water filtration: A practical, effective solution for providing sustained access to safe drinking water in the developing world. Environ Sci Technol (2008) 3.05
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am J Psychiatry (2007) 2.84
Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am J Psychiatry (2003) 2.69
Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry (2007) 2.60
Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull (2008) 2.59
Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry (2005) 2.59
A cognitive neuroscience-based computerized battery for efficient measurement of individual differences: standardization and initial construct validation. J Neurosci Methods (2009) 2.55
Age group and sex differences in performance on a computerized neurocognitive battery in children age 8-21. Neuropsychology (2012) 2.54
The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr Bull (2006) 2.53
Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA (2003) 2.51
An fMRI study of facial emotion processing in patients with schizophrenia. Am J Psychiatry (2002) 2.50
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ (2002) 2.46
Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol (2002) 2.39
Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry (2008) 2.29
Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf (2002) 2.12
Differences in facial expressions of four universal emotions. Psychiatry Res (2004) 2.11
Working memory for complex figures: an fMRI comparison of letter and fractal n-back tasks. Neuropsychology (2002) 2.07
Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med (2003) 2.02
Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis (2006) 1.96
Leftward asymmetry in relative fiber density of the arcuate fasciculus. Neuroreport (2005) 1.96
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biol Psychiatry (2008) 1.86
Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol (2009) 1.85
Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics (2011) 1.84
Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis (2004) 1.83
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med (2005) 1.82
Gender difference in neural response to psychological stress. Soc Cogn Affect Neurosci (2007) 1.81
Baby Schema in Infant Faces Induces Cuteness Perception and Motivation for Caretaking in Adults. Ethology (2009) 1.79
Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf (2010) 1.78
Quality of care indicators for gout management. Arthritis Rheum (2004) 1.77
A meta-analysis of emotion perception and functional outcomes in schizophrenia. Schizophr Res (2012) 1.77
Artifacts in T1 rho-weighted imaging: compensation for B(1) and B(0) field imperfections. J Magn Reson (2007) 1.77
Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol (2006) 1.76
Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance. Infect Control Hosp Epidemiol (2005) 1.71
Telling truth from lie in individual subjects with fast event-related fMRI. Hum Brain Mapp (2005) 1.70
Sex differences in temporo-limbic and frontal brain volumes of healthy adults. Cereb Cortex (2002) 1.69
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst (2012) 1.69
Quality of Medicaid and Medicare data obtained through Centers for Medicare and Medicaid Services (CMS). Med Care (2007) 1.66
Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures. Schizophr Bull (2006) 1.64
Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia. Am J Psychiatry (2004) 1.64
The other-race effect in face processing among African American and Caucasian individuals with schizophrenia. Am J Psychiatry (2008) 1.63
Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia. Pharmacoepidemiol Drug Saf (2011) 1.63
Reemergence of gram-negative health care-associated bloodstream infections. Arch Intern Med (2006) 1.63
Working memory deficit as a core neuropsychological dysfunction in schizophrenia. Am J Psychiatry (2003) 1.60
Impairment in the specificity of emotion processing in schizophrenia. Am J Psychiatry (2006) 1.58
Facial emotion recognition in schizophrenia: when and why does it go awry? Schizophr Res (2007) 1.58
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry (2004) 1.58
Long-term effects of culture of preimplantation mouse embryos on behavior. Proc Natl Acad Sci U S A (2004) 1.57
The Penn Conditional Exclusion Test: a new measure of executive-function with alternate forms of repeat administration. Arch Clin Neuropsychol (2004) 1.57
Age-related differences in brain activation during emotional face processing. Neurobiol Aging (2002) 1.54
Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study. PLoS One (2011) 1.54
Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend (2009) 1.53
Facial recognition deficits and cognition in schizophrenia. Schizophr Res (2004) 1.52
A genome screen for quantitative trait loci influencing schizophrenia and neurocognitive phenotypes. Am J Psychiatry (2008) 1.51
Baby schema modulates the brain reward system in nulliparous women. Proc Natl Acad Sci U S A (2009) 1.50
A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis. Schizophr Res (2006) 1.49
Sensory contributions to impaired emotion processing in schizophrenia. Schizophr Bull (2009) 1.48
Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact. Am J Med (2006) 1.47
Levels-of-processing effect on frontotemporal function in schizophrenia during word encoding and recognition. Am J Psychiatry (2005) 1.47
Neural substrates for functionally discriminating self-face from personally familiar faces. Hum Brain Mapp (2006) 1.46
Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J (2004) 1.45